What patients praise: Professional service quality and medication effectiveness are cited as primary positives in consumer feedback The established platform infrastructure, years of telehealth experience across multiple conditions, with licensed providers, and a mature clinical review system Insurance coordination support for brand-name GLP-1 access, which some patients report makes a meaningful difference in navigating prior authorization Common complaints: Response times and pricing clarity are the most frequently cited concerns
As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Screening There is no evidence worldwide to support the use of screening programs at a population level [28, 29], although there is recent research interest in using risk assessment models to identify people at higher risk of melanoma, for personalised approaches to surveillance [3032]
Our experience working with peptide research protocols shows this single sequencing mistake accounts for more dosing failures than contamination or improper storage combined
How to use: Recommendation for Use: Take 2-3 capsules daily
So, when picking between them, it really comes down to your preferences and what your doc recommends
